-
Microbiota-derived small molecule genotoxins: host interactions and ecological impact in the gut ecosystem. Gut Microbes (IF 12.2) Pub Date : 2024-11-18 Ellen L Zechner,Sabine Kienesberger
The human intestinal tract is densely colonized by a microbial community that is subject to intense competition. Bacteria in this complex habitat seek to outcompete their neighbors for nutrients and eliminate competitors with antibacterial toxins. Antagonism can be mediated by diverse effectors including toxic proteins and small molecule inhibitors that are released extracellularly or delivered by
-
Effects of gastric bypass bariatric surgery on gut microbiota in patients with morbid obesity. Gut Microbes (IF 12.2) Pub Date : 2024-11-17 Urja Amin,Dora Huang,Arun Dhir,Anya E Shindler,Ashley E Franks,Colleen J Thomas
The Western diet is associated with gastrointestinal dysbiosis, an active contributor to the pathophysiology of obesity and its comorbidities. Gastrointestinal dysbiosis is strongly linked to increased adiposity, low-grade inflammation, dyslipidaemia, and insulin resistance in individuals with morbid obesity. Bariatric bypass surgery remains the most effective treatment for achieving significant weight
-
Dysrupted microbial tryptophan metabolism associates with SARS-CoV-2 acute inflammatory responses and long COVID. Gut Microbes (IF 12.2) Pub Date : 2024-11-17 Lu Yao,Hannah Devotta,Junhui Li,Nonhlanhla Lunjani,Corinna Sadlier,Aonghus Lavelle,Werner C Albrich,Jens Walter,Paul W O'Toole,Liam O'Mahony
Protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and risk of long COVID has been associated with the depletion or over-abundance of specific taxa within the gut microbiome. However, the microbial mechanisms mediating these effects are not yet known. We hypothesized that altered microbial production of tryptophan and its downstream derivatives might contribute
-
Prebiotics in food and dietary supplements: a roadmap to EU health claims. Gut Microbes (IF 12.2) Pub Date : 2024-11-15 Kieran Tuohy,Elaine E Vaughan,Lucien F Harthoorn,Ellen E Blaak,Philip W J Burnet,Alessandro Busetti,Anirikh Chakrabarti,Nathalie Delzenne,Paul de Vos,Louise Dye,Damien Guillemet,Lesley A Houghton,Alwine F M Kardinaal,Cath Mersh,Kathy Musa-Veloso,Annegret Nielsen,Justyna Palasinska,Seppo Salminen,Gemma Walton,Naomi Venlet,Charlotte Hubermont,Philip C Calder
Numerous studies have established that prebiotic ingredients in foods and dietary supplements may play a role in supporting human health. Over the three decades that have passed since prebiotics were first defined as a concept, research has revealed a complex universe of prebiotic-induced changes to the human microbiota. There are strong indications of a direct link between these prebiotic-induced
-
Induction of intercrypt goblet cells upon bacterial infection: a promising therapeutic target to restore the mucosal barrier. Gut Microbes (IF 12.2) Pub Date : 2024-11-14 Renaud Léonard,Ewa Pasquereau-Kotula,Edwige Madec,Benjamin Marsac,Adriana Mihalache,Laurence du Merle,Jordan Denis,Corentin Spriet,Philippe Sansonetti,Shaynoor Dramsi,Catherine Robbe Masselot
Intestinal mucins play a crucial role in the mucosal barrier, serving as the body's initial defense against microorganisms. However, how the host regulates the secretion and glycosylation of these mucins in response to bacterial invasion remains unclear. Our study demonstrates that when exposed to Streptococcus gallolyticus (SGG), a gut pathobiont, the host mucosa promptly adjusts the behavior of specialized
-
Mechanisms of gut bacterial metabolism of dietary polyphenols into bioactive compounds. Gut Microbes (IF 12.2) Pub Date : 2024-11-14 Sara Alqudah,Jan Claesen
The fruits and vegetables we consume as part of our diet are rich in bioactive metabolites that can prevent and ameliorate cardiometabolic diseases, cancers, and neurological conditions. Polyphenols are a major metabolite family that has been intensively investigated in this context. However, for these compounds to exert their optimal bioactivity, they rely on the enzymatic capacity of an individual's
-
Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health. Gut Microbes (IF 12.2) Pub Date : 2024-11-13 Mohan Li,Bingyong Mao,Xin Tang,Qiuxiang Zhang,Jianxin Zhao,Wei Chen,Shumao Cui
Lactic acid bacteria derived extracellular vesicles (LAB-EVs) are nano-sized and carry a variety of biological cargoes. LAB-EVs have proven to be potential mediators of intercellular communication, serving not only the parental bacteria but also the host cell in both physiology and pathology. LAB-EVs are therapeutically beneficial in various diseases through a cell-free strategy. Particularly, EVs
-
Differential contributions of the gut microbiota and metabolome to pathomechanisms in ulcerative colitis: an in vitro analysis. Gut Microbes (IF 12.2) Pub Date : 2024-11-13 Jonas Poppe,Leen Boesmans,Sara Vieira-Silva,Lise Deroover,Raul Tito,Doris Vandeputte,Greet Vandermeulen,Vicky De Preter,Jeroen Raes,Severine Vermeire,Gwen Falony,Kristin Verbeke
The gut microbiota has been implicated in onset and progression of ulcerative colitis (UC). Here, we assess potential causal involvement of the microbiota and -associated fecal water (FW) metabolome in altering key functional parameters of the colonic epithelium. Fecal samples were collected from N = 51 healthy controls (HC), N = 36 patients with active UC (UC-A), and N = 41 subjects in remission N = 41
-
Gut microbial metabolism of bile acids modifies the effect of Mediterranean diet interventions on cardiometabolic risk in a randomized controlled trial. Gut Microbes (IF 12.2) Pub Date : 2024-11-13 Peipei Gao,Ehud Rinott,Danyue Dong,Zhendong Mei,Fenglei Wang,Yuxi Liu,Omer Kamer,Anat Yaskolka Meir,Kieran M Tuohy,Matthias Blüher,Michael Stumvoll,Meir J Stampfer,Iris Shai,Dong D Wang
Bile acids (BAs) undergo extensive microbial metabolism in the gut and exert hormone-like functions on physiological processes underlying metabolic risk. However, the extent to which gut BA profiles predict cardiometabolic risk and explain individual responses to dietary interventions in humans is still unclear. In the DIRECT-PLUS Trial, we conducted a multi-omics analysis of 284 participants randomized
-
Stability in fecal metabolites amid a diverse gut microbiome composition: a one-month longitudinal study of variability in healthy individuals. Gut Microbes (IF 12.2) Pub Date : 2024-11-12 Matteo Sangermani,Indri Desiati,Solveig M Jørgensen,Jia V Li,Trygve Andreassen,Tone F Bathen,Guro F Giskeødegård
An extensive network of microbial-host interactions exists in the gut, making the gut microbiome a complex ecosystem to untangle. The microbial composition and the fecal metabolites are important readouts to investigate intricate microbiota-diet-host interplay. However, this ecosystem is dynamic, and it is of interest to understand the degree and timescale of changes occurring in the gut microbiota
-
Biosynthetic potential of the gut microbiome in longevous populations. Gut Microbes (IF 12.2) Pub Date : 2024-11-11 Sheng Liu,Zhao Zhang,Xudong Wang,Yan Ma,Hengfang Ruan,Xing Wu,Baoxia Li,Xiangyu Mou,Tao Chen,Zhengqi Lu,Wenjing Zhao
Gut microbiome plays a pivotal role in combating diseases and facilitating healthy aging, and natural products derived from biosynthetic gene clusters (BGCs) of the human microbiome exhibit significant biological activities. However, the natural products of the gut microbiome in long-lived populations remain poorly understood. Here, we integrated six cohorts of long-lived populations, encompassing
-
Immunogenicity and cross-protective efficacy induced by delayed attenuated Salmonella with regulated length of lipopolysaccharide in mice. Gut Microbes (IF 12.2) Pub Date : 2024-11-11 Xiaoping Bian,Qing Liu,Yaolin Chen,Wenjin Zhang,Mengru Li,Xiaofen Zhang,Liu Yang,Yonghong Liao,Qingke Kong
Non-typhoidal Salmonella enterica (NTS) is a major global foodborne pathogen that poses a major public health concern worldwide, and no vaccines are available for protecting against infection of multiple Salmonella serotypes, therefore, the development of Salmonella vaccines to provide broad protection is valuable. In this work, we aimed to regulate lipopolysaccharide (LPS) synthesis of live Salmonella
-
KRAS mutations promote the intratumoral colonization of enterotoxigenic bacteroides fragilis in colorectal cancer through the regulation of the miRNA3655/SURF6/IRF7/IFNβ axis. Gut Microbes (IF 12.2) Pub Date : 2024-11-10 Yizhen Chen,Shaolin Liu,Song Tan,Yuanyuan Zheng,Yifan Chen,Changshun Yang,Shengtao Lin,Yulong Mi,Weihua Li
KRAS mutations are associated with poor prognosis in colorectal cancer (CRC). Although the association between the gut microbiota and CRC has been extensively documented, it is unclear whether KRAS mutations can regulate the gut microbiota. Metagenomics has identified changes in the diversity of the gut microbiota in CRC due to KRAS mutations. Specifically, KRAS mutations positively correlate with
-
Reverse engineering the Gut-Brain Axis and microbiome-metabolomics for symbiotic/pathogenic balance in neurodegenerative diseases. Gut Microbes (IF 12.2) Pub Date : 2024-11-10 Muhammad Usman Munir,Syed Aoun Ali,Ka Hang Karen Chung,Aleksandr Kakinen,Ibrahim Javed,Thomas Paul Davis
Deciphering the molecular communications along the gut-brain axis can help in understanding the pathophysiology of neurodegenerative diseases and exploiting the gut microbiome for therapeutics. However, gut microbes and their metabolites have a multifaceted role in mediating both brain physiology and neurodegenerative pathology. There is a lack of understanding of how and when this role is tipped in
-
Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus. Gut Microbes (IF 12.2) Pub Date : 2024-11-09 Shengnan Huang,Fangfang Li,Chunhua Quan,Dan Jin
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease characterized by destruction of pancreatic β-cells, leading to insulin deficiency and hyperglycemia, and its incidence is increasing year by year. The pathogenesis of T1DM is complex, mainly including genetic and environmental factors. Intestinal flora is the largest microbial community in the human body and plays a very important role
-
Adhesin RadD: the secret weapon of Fusobacterium nucleatum. Gut Microbes (IF 12.2) Pub Date : 2024-11-09 Dingjiacheng Jia,Shujie Chen
Fusobacterium nucleatum can promote colorectal cancer (CRC) development through a variety of virulence proteins. Zhang et al. recently identified an adhesin RadD, for Fusobacterium nucleatum adhesion to CRC. Targeting the interaction between RadD and CD147 will provide a new strategy for CRC treatment. This Commentary and View not only summarizes the research highlights but also discusses the possibility
-
Impact of an intranasal L-DBF vaccine on the gut microbiota in young and elderly mice. Gut Microbes (IF 12.2) Pub Date : 2024-11-09 Ti Lu,Aaron C Ericsson,Zackary K Dietz,Alexa K Cato,Lyndon M Coghill,William D Picking,Wendy L Picking
Shigella spp. cause bacillary dysentery (shigellosis) with high morbidity and mortality in low- and middle-income countries. Infection occurs through the fecal-oral route and can be devastating for vulnerable populations, including infants and the elderly. These bacteria invade host cells using a type III secretion system (T3SS). No licensed vaccine yet exists for shigellosis, but we have generated
-
Colonization resistance: the role of gut microbiota in preventing Salmonella invasion and infection. Gut Microbes (IF 12.2) Pub Date : 2024-11-08 Lei Deng,Shaohui Wang
The human gastrointestinal tract is colonized by a complex microbial ecosystem, the gut microbiota, which is pivotal in maintaining host health and mediating resistance to diseases. This review delineates colonization resistance (CR), a critical defensive mechanism employed by the gut microbiota to safeguard against pathogenic bacterial invasions, notably by Salmonella. We detail the mechanisms through
-
PPARα exacerbates Salmonella Typhimurium infection by modulating the immunometabolism and macrophage polarization. Gut Microbes (IF 12.2) Pub Date : 2024-11-07 Jessica R Taddeo,Naomi Wilson,Anita Kowal,Joris Beld,Klein-Szanto Andres,Çagla Tükel,Vincent C Tam
Salmonella enterica serovar Typhimurium (STm) is a causative pathogen for robust inflammatory gastrointestinal disease and can lead to systemic infection. Eicosanoids, bioactive lipid mediators, play a crucial role in modulating both the induction and resolution of inflammatory responses during an infection. A subset of eicosanoids activates PPARs, nuclear receptor/transcription factors that regulate
-
The effects of gut microbiota on appetite regulation and the underlying mechanisms Gut Microbes (IF 12.2) Pub Date : 2024-11-06 Miao Yu, Bing Yu, Daiwen Chen
Appetite, a crucial aspect regulated by both the central nervous system and peripheral hormones, is influenced by the composition and dynamics of the intestinal microbiota, as evidenced by recent r...
-
Transfer of microbiota from lean donors in combination with prebiotics prevents excessive weight gain and improves gut-brain vagal signaling in obese rats Gut Microbes (IF 12.2) Pub Date : 2024-11-01 Dulce M. Minaya, Jiyoung S Kim, Rebecca Kirkland, Jillian Allen, Sitara Cullinan, Neil Maclang, Guillaume de Lartigue, Claire de La Serre
Gastrointestinal (GI) microbiota plays an active role in regulating the host’s immune system and metabolism, as well as certain pathophysiological processes. Diet is the main factor modulating GI m...
-
Giardia antagonizes beneficial functions of indigenous and therapeutic intestinal bacteria during protein deficiency. Gut Microbes (IF 12.2) Pub Date : 2024-11-05 Aadra P Bhatt,Jason W Arnold,Muyiwa Awoniyi,Shan Sun,Verônica Feijoli Santiago,Deniz Coskuner,Pedro Henrique Quintela,Kenneth Walsh,Jamie Xiao,Renay Ngobeni-Nyambi,Brenna Hansen,Ajay S Gulati,Ian M Carroll,M Andrea Azcarate-Peril,Anthony A Fodor,Jonathan Swann,Luther A Bartelt
Undernutrition in children commonly disrupts the structure and function of the small intestinal microbial community, leading to enteropathies, compromised metabolic health, and impaired growth and development. The mechanisms by which diet and microbes mediate the balance between commensal and pathogenic intestinal flora remain elusive. In a murine model of undernutrition, we investigated the direct
-
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome. Gut Microbes (IF 12.2) Pub Date : 2024-11-05 Rohma Ghani,Despoina Chrysostomou,Lauren A Roberts,Madhumitha Pandiaraja,Julian R Marchesi,Benjamin H Mullish
Faecal/intestinal microbiota transplant (FMT/IMT) is an efficacious treatment option for recurrent Clostridioides difficile infection, which has prompted substantial interest in FMT's potential role in the management of a much broader range of diseases associated with the gut microbiome. Despite its promise, the success rates of FMT in these other settings have been variable. This review critically
-
A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome Gut Microbes (IF 12.2) Pub Date : 2024-10-31 Ayesha Shah, Yeong Yeh Lee, Hidekazu Suzuki, Joash Tan-Loh, Kewin Tien Ho Siah, Kok-Ann Gwee, Thomas Fairlie, Nicholas J. Talley, Uday C Ghoshal, Yen-Po Wang, Yong Sung Kim, Gerald Holtmann
The International Rome Committee defines Disorders of Gut-Brain Interactions (DGBI) based upon distinct combinations of chronic and/or recurrent unexplained gastrointestinal symptoms. Yet patients ...
-
Symbiotic probiotic communities with multiple targets successfully combat obesity in high-fat-diet-fed mice Gut Microbes (IF 12.2) Pub Date : 2024-11-03 Dingming Guo, Yun Deng, Qianqian Yang, Min Li, Xiangfeng Wang, Xuchun Wan, Junqing He, Ying Xu, Wenxin Huang, Guohua Lin, Ya Xu, Yi Sun, Ruilin Zhang, Wei-Hua Chen, Zhi Liu
Probiotics hold great potential for treating metabolic diseases such as obesity. Given the complex and multifactorial nature of these diseases, research on probiotic combination with multiple targe...
-
Oral administration of Lactobacillus casei DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis -MEP1) Gut Microbes (IF 12.2) Pub Date : 2024-11-01 Imerio Angriman, Melania Scarpa, Edoardo Savarino, Ilaria Patuzzi, Alessandra Rigo, Andromachi Kotsafti, Astghik Stepanyan, Elisa Sciuto, Francesco Celotto, Silvia Negro, Antonino Caruso, Cesare Ruffolo, Romeo Bardini, Salvatore Pucciarelli, Brigida Barberio, Gaya Spolverato, Fabiana Zingone, Renata D’Incà, Ignazio Castagliuolo, Marco Scarpa
Pouchitis is an idiopathic inflammatory disease that may occur in ileal pouches, and it can lead to ileal pouch failure. This was a single-center, randomized, double-blinded, placebo-controlled tri...
-
The case for microbial intervention at weaning Gut Microbes (IF 12.2) Pub Date : 2024-10-28 Julia N. Flores, Jean-Bernard Lubin, Michael A. Silverman
Weaning, the transition from a milk-based diet to solid food, coincides with the most significant shift in gut microbiome composition in the lifetime of most mammals. Notably, this period also mark...
-
A gut feeling of statin Gut Microbes (IF 12.2) Pub Date : 2024-10-29 Jianqing She, Lizhe Sun, Yue Yu, Heze Fan, Xia Li, Xinyu Zhang, Xiaozhen Zhuo, Manyun Guo, Junhui Liu, Peining Liu, Gulinigaer Tuerhongjiang, Bin Du, Hongbing Li, Jun Yu, Zuyi Yuan, Yue Wu
Statins, known as HMG-CoA reductase inhibitors, are widely utilized to reduce blood cholesterol levels and possess pleiotropic effects, including the influence on inflammation and macrophage prolif...
-
Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study Gut Microbes (IF 12.2) Pub Date : 2024-10-29 Yao Wang, Jiarui Chen, Yueqiong Ni, Yan Liu, Xiang Gao, Michael Andrew Tse, Gianni Panagiotou, Aimin Xu
The importance of gut microbes in mediating the benefits of lifestyle intervention is increasingly recognized. However, compared to the bacterial microbiome, the role of intestinal fungi in exercis...
-
Lactobacillaceae differentially impact butyrate-producing gut microbiota to drive CNS autoimmunity Gut Microbes (IF 12.2) Pub Date : 2024-10-27 Theresa L. Montgomery, Lucinda C. Toppen, Korin Eckstrom, Eamonn R. Heney, Josephine J. Kennedy, Matthew J. Scarborough, Dimitry N. Krementsov
Short-chain fatty acids (SCFAs), produced by the gut microbiota, are thought to exert an anti-inflammatory effect on the host immune system. The levels of SCFAs and abundance of the microbiota that...
-
Fecal microbial marker panel for aiding diagnosis of autism spectrum disorders Gut Microbes (IF 12.2) Pub Date : 2024-10-28 Yating Wan, Oscar W.H. Wong, Hein M Tun, Qi Su, Zhilu Xu, Whitney Tang, Suk Ling Ma, Sandra Chan, Francis K L Chan, Siew C Ng
Accumulating evidence suggests that gut microbiota alterations influence brain function and could serve as diagnostic biomarkers and therapeutic targets. The potential of using fecal microbiota sig...
-
Regulatory mechanism of cysteine-dependent methionine biosynthesis in Bifidobacterium longum: insights into sulfur metabolism in gut microbiota Gut Microbes (IF 12.2) Pub Date : 2024-10-28 You-Tae Kim, Joon-Gi Kwon, Daniel J. O’Sullivan, Ju-Hoon Lee
Sulfur, a critical element for bacterial growth, is not directly utilized by bifidobacteria, rendering the sulfur-containing amino acid biosynthesis pathway, particularly for cysteine and methionin...
-
How important are fatty acids in human health and can they be used in treating diseases? Gut Microbes (IF 12.2) Pub Date : 2024-10-27 Leon M. T. Dicks
Most of the short-chain fatty acids (SCFAs) are produced by Bifidobacterium, Lactobacillus, Lachnospiraceae, Blautia, Coprococcus, Roseburia, Facealibacterium and Oscillospira. Butyrate (C4H7O2−) s...
-
Correction Gut Microbes (IF 12.2) Pub Date : 2024-10-28
Published in Gut Microbes (Vol. 16, No. 1, 2024)
-
Fecal samples and rectal swabs adequately reflect the human colonic luminal microbiota Gut Microbes (IF 12.2) Pub Date : 2024-10-22 Julia Rode, Linnea Brengesjö Johnson, Julia König, Ignacio Rangel, Lars Engstrand, Dirk Repsilber, Robert J Brummer
The appropriateness of the fecal microbiota to adequately reflect the gut microbiota composition from more difficult to access luminal content at different colonic locations has been debated. Here,...
-
Candida tropicalis-derived vitamin B3 exerts protective effects against intestinal inflammation by promoting IL-17A/IL-22-dependent epithelial barrier function Gut Microbes (IF 12.2) Pub Date : 2024-10-27 Ha T Doan, Li-Chieh Cheng, Yi-Ling Chiu, Yuan-Kai Cheng, Cheng-Chih Hsu, Yee-Chun Chen, Hsiu-Jung Lo, Hao-Sen Chiang
Candida tropicalis-a prevalent gut commensal fungus in healthy individuals – contributes to intestinal health and disease. However, how commensal C. tropicalis influences intestinal homeostasis and...
-
Correction Gut Microbes (IF 12.2) Pub Date : 2024-10-25
Published in Gut Microbes (Vol. 16, No. 1, 2024)
-
Muropeptides and muropeptide transporters impact on host immune response Gut Microbes (IF 12.2) Pub Date : 2024-10-22 Maria Lucia Orsini Delgado, Joao Gamelas Magalhaes, Rachel Morra, Antonietta Cultrone
In bacteria, the cell envelope is the key element surrounding and protecting the bacterial content from mechanical or osmotic damages. It allows the selective interchanges of solutes, ions, cellula...
-
The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease Gut Microbes (IF 12.2) Pub Date : 2024-10-24 Xiaofan Song, Xina Dou, Jiajing Chang, Xiaonan Zeng, Qinhong Xu, Chunlan Xu
The current studies have shown that the occurrence and development of chronic obstructive pulmonary disease (COPD) are closely related to the changes in gut health and its microenvironment, and eve...
-
Morphine-induced intestinal microbial dysbiosis drives TLR-dependent IgA targeting of gram-positive bacteria and upregulation of CD11b and TLR2 on a sub-population of IgA+ B cells Gut Microbes (IF 12.2) Pub Date : 2024-10-23 Nicolas Vitari, Salma Singh, Junyi Tao, Bridget Truitt, Udhghatri Kolli, Richa Jalodia, Kathryn M LaPorte, Yaa Abu, Danielle Antoine, Umakant Sharma, Sabita Roy
IgA binding dictates the composition of the intestinal microbiome and reflects dysbiotic states during chronic disease. Both pathogenic and commensal bacteria differentially bind to IgA with varyin...
-
Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications Gut Microbes (IF 12.2) Pub Date : 2024-10-18 Enriqueta Garcia-Gutierrez, A. Kate O’Mahony, Reinaldo Sousa Dos Santos, Laura Marroquí, Paul D. Cotter
Diabetes mellitus can be subdivided into several categories based on origin and clinical characteristics. The most common forms of diabetes are type 1 (T1D), type 2 diabetes (T2D) and gestational d...
-
Inflammasome activation links enteric Salmonella Typhimurium infection to a rapid, cytokine-dependent increase in intestinal mucin release Gut Microbes (IF 12.2) Pub Date : 2024-10-20 Xiao Han, Joannie M. Allaire, Shauna M. Crowley, Jocelyn J. Chan, Kelly Lau, Conghao Zhang, Simon A. Hirota, Kirk Bergstrom, Leigh A. Knodler, Bruce A. Vallance
The host restricts Salmonella enterica serovar Typhimurium infection of the gut via inflammasome-dependent sloughing of infected epithelial cells. Here we determined that concurrent caspase 1/11-de...
-
Gut microbiota determines the fate of dietary fiber-targeted interventions in host health Gut Microbes (IF 12.2) Pub Date : 2024-10-17 Wenjing Wang, Zhexin Fan, Qingqing Yan, Tong Pan, Jing Luo, Yijiang Wei, Baokun Li, Zhifeng Fang, Wenwei Lu
Epidemiological investigation confirmed that the intake of dietary fiber (DF) is closely related to human health, and the most important factor affecting the physiological function of DF, besides i...
-
Species- and subspecies-level characterization of health-associated bacterial consortia that colonize the human gut during infancy Gut Microbes (IF 12.2) Pub Date : 2024-10-20 Samuel S. Minot, Koshlan Mayer-Blackwell, Andrew Fiore-Gartland, Andrew Johnson, Steven Self, Parveen Bhatti, Lena Yao, Lili Liu, Xin Sun, Yi Jinfa, James Kublin
The human gut microbiome develops rapidly during infancy, a key window of development coinciding with the maturation of the adaptive immune system. However, little is known about the microbiome gro...
-
High-fat diet-induced L-saccharopine accumulation inhibits estradiol synthesis and damages oocyte quality by disturbing mitochondrial homeostasis Gut Microbes (IF 12.2) Pub Date : 2024-10-16 Jingyi Wen, Yanzhi Feng, Liru Xue, Suzhen Yuan, Qian Chen, Aiyue Luo, Shixuan Wang, Jinjin Zhang
High-fat diet (HFD) has been linked to female infertility. However, the specific age at which HFD impacts ovarian function and the underlying mechanisms remain poorly understood. Here, we administe...
-
Entamoeba muris mitigates metabolic consequences of high-fat diet in mice Gut Microbes (IF 12.2) Pub Date : 2024-10-13 Maryline Roy, Anne Dumay, Sandrine Adiba, Sylvana Rozes, Seiki Kobayashi, Valérie Paradis, Catherine Postic, Dominique Rainteau, Eric Ogier-Denis, Maud Le Gall, Ulrich Meinzer, Emilie Viennois, Maite Casado-Bedmar, Alexis Mosca, Jean-Pierre Hugot
Metabolic syndrome (MetS) is a cluster of several human conditions including abdominal obesity, hypertension, dyslipidemia, and hyperglycemia, all of which are risk factors of type 2 diabetes, card...
-
Clostridium sporogenes-derived metabolites protect mice against colonic inflammation Gut Microbes (IF 12.2) Pub Date : 2024-10-14 Felix F. Krause, Kira I. Mangold, Anna-Lena Ruppert, Hanna Leister, Anne Hellhund-Zingel, Aleksandra Lopez Krol, Jelena Pesek, Bernhard Watzer, Sarah Winterberg, Hartmann Raifer, Kai Binder, Ralf Kinscherf, Alesia Walker, Wolfgang A. Nockher, R. Verena Taudte, Wilhelm Bertrams, Bernd Schmeck, Anja A. Kühl, Britta Siegmund, Rossana Romero, Maik Luu, Stephan Göttig, Isabelle Bekeredjian-Ding, Ulrich
Gut microbiota-derived metabolites play a pivotal role in the maintenance of intestinal immune homeostasis. Here, we demonstrate that the human commensal Clostridium sporogenes possesses a specific...
-
Controlled infection with cryopreserved human hookworm induces CTLA-4 expression on Tregs and upregulates tryptophan metabolism Gut Microbes (IF 12.2) Pub Date : 2024-10-16 Francesco Vacca, Thomas C. Mules, Mali Camberis, Brittany Lavender, Sophia-Louise Noble, Alissa Cait, Kate Maclean, John Mamum, Bibek Yumnam, Tama Te Kawa, Laura Ferrer-Font, Jeffry S. Tang, Olivier Gasser, Graham Le Gros, Stephen Inns
Infecting humans with controlled doses of helminths, such as human hookworm (termed hookworm therapy), is proposed to prevent or treat various intestinal and extraintestinal diseases. However, full...
-
Giardia spp.-induced microbiota dysbiosis disrupts intestinal mucin glycosylation Gut Microbes (IF 12.2) Pub Date : 2024-10-16 Elena Fekete, Thibault Allain, Olivia Sosnowski, Stephanie Anderson, Ian A. Lewis, Andre G. Buret
Infection with the protozoan parasite Giardia duodenalis (syn. intestinalis, lamblia) has been associated with intestinal mucus disruptions and microbiota dysbiosis. The mechanisms remain incomplet...
-
ChiA: a major player in the virulence of Crohn’s disease-associated adherent and invasive Escherichia coli (AIEC) Gut Microbes (IF 12.2) Pub Date : 2024-10-14 Margot Fargeas, Frederic Faure, Clara Douadi, Caroline Chevarin, Aurélien Birer, Adeline Sivignon, Michael Rodrigues, Jérémy Denizot, Elisabeth Billard, Nicolas Barnich, Anthony Buisson
We investigated the role of ChiA and its associated polymorphisms in the interaction between Crohn’s disease (CD)-associated adherent-invasive Escherichia coli (AIEC) and intestinal mucosa. We obse...
-
Normalization of short-chain fatty acid concentration by bacterial count of stool samples improves discrimination between eubiotic and dysbiotic gut microbiota caused by Clostridioides difficile infection- Gut Microbes (IF 12.2) Pub Date : 2024-10-12 Anna Sayol-Altarriba, Andrea Aira, Anna Villasante, Rosa Albarracín, Joana Faneca, Gregori Casals, José Luis Villanueva-Cañas, Climent Casals-Pascual
Short-chain fatty acids (SCFAs) represent a cornerstone of gut health, serving as critical mediators of immune modulation and overall host homeostasis. Patients with dysbiosis caused by Clostridioi...
-
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies Gut Microbes (IF 12.2) Pub Date : 2024-10-12 Madeline Krieger, Mingzhe Guo, Justin Merritt
The Gram-negative anaerobic species Fusobacterium nucleatum was originally described as a commensal organism from the human oral microbiome. However, it is now widely recognized as a key inflammoph...
-
Microbiome’s role in musculoskeletal health through the gut-bone axis insights Gut Microbes (IF 12.2) Pub Date : 2024-10-10 Zhengrui Li, Qi Wang, Xufeng Huang, Yinteng Wu, Dan Shan
The interplay between the human microbiome and the musculoskeletal system represents a burgeoning field of research with profound implications for understanding and treating musculoskeletal disorde...
-
Microbiota-derived acetate is associated with functionally optimal virus-specific CD8+ T cell responses to influenza virus infection via GPR43-dependent metabolic reprogramming Gut Microbes (IF 12.2) Pub Date : 2024-10-10 Jingjing Qiu, Chunwei Shi, Yanan Zhang, Tianming Niu, Shuxian Chen, Guilian Yang, Shu Jeffrey Zhu, Chunfeng Wang
The microbiota-associated factors that affect host susceptibility and adaptive immunity to influenza A virus (IAV) infection have not been fully elucidated. By comparing the microbiota composition ...
-
Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products Gut Microbes (IF 12.2) Pub Date : 2024-10-08 Do-Yeon Kim, So-Yeon Lee, Jae-Yun Lee, Tae Woong Whon, June-Young Lee, Che Ok Jeon, Jin-Woo Bae
The human intestine hosts a complex ecosystem of various microorganisms, collectively known as the gut microbiome, which significantly impacts human health. Disruptions in the gut microbiome are li...
-
Comparative analysis of the duodenojejunal microbiome with the oral and fecal microbiomes reveals its stronger association with obesity and nutrition Gut Microbes (IF 12.2) Pub Date : 2024-10-07 Emilie Steinbach, Eugeni Belda, Rohia Alili, Solia Adriouch, Charlène J. G. Dauriat, Gianfranco Donatelli, Jean-Loup Dumont, Filippo Pacini, Thierry Tuszynski, Véronique Pelloux, Flavien Jacques, Laura Creusot, Emavieve Coles, Paul Taillandier, Marta Vazquez Gomez, Davide Masi, Véronique Mateo, Sébastien André, Melissa Kordahi, Christine Rouault, Jean-Daniel Zucker, Harry Sokol, Laurent Genser, Benoit
The intestinal microbiota is increasingly recognized as a crucial player in the development and maintenance of various chronic conditions, including obesity and associated metabolic diseases. While...
-
Helicobacter pylori PldA modulates TNFR1-mediated p38 signaling pathways to regulate macrophage responses for its survival Gut Microbes (IF 12.2) Pub Date : 2024-10-06 Wei Yang Sit, Mei-Ling Cheng, Tsan-Jan Chen, Chia-Jo Chen, Bo-Nian Chen, Ding-Jun Huang, Pei-Lien Chen, Yun-Ching Chen, Chi-Jen Lo, Deng-Chyang Wu, Wan-Chen Hsieh, Chung-Ting Chang, Ruey-Hwa Chen, Wen-Ching Wang
Helicobacter pylori, a dominant member of the gastric microbiota was associated with various gastrointestinal diseases and presents a significant challenge due to increasing antibiotic resistance. ...
-
Gut microbiota genome features associated with brain injury in extremely premature infants Gut Microbes (IF 12.2) Pub Date : 2024-10-07 David Seki, Rasmus Kirkegaard, Jay Osvatic, Bela Hausmann, Joana Séneca, Petra Pjevac, Angelika Berger, Lindsay J Hall, Lukas Wisgrill, David Berry
Severe brain damage is common among premature infants, and the gut microbiota has been implicated in its pathology. Although the order of colonizing bacteria is well described, the mechanisms under...
-
BPP43_05035 is a Brachyspira pilosicoli cell surface adhesin that weakens the integrity of the epithelial barrier during infection Gut Microbes (IF 12.2) Pub Date : 2024-09-30 Anandi Rajan, Pablo Gallego, Brendan Dolan, Piyush Patel, Chinmay Dwibedi, Ana S. Luis, Sergio Trillo-Muyo, Liisa Arike, Sjoerd van der Post, Magnus Simrén, Thaher Pelaseyed
The anaerobic spirochete Brachyspira causes intestinal spirochetosis, characterized by the intimate attachment of bacterial cells to the colonic mucosa, potentially leading to symptoms such as diar...
-
Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice Gut Microbes (IF 12.2) Pub Date : 2024-10-01 Brett R. Loman, Zainab Alzoubi, Alexis J. Lynch, Robert M. Jaggers, Kelley Jordan, Corena V. Grant, Lynette K. Rogers, Leah M. Pyter, Michael T. Bailey
Balanced interactions between the enteric microbiota and enterohepatic organs are essential to bile acid homeostasis, and thus normal gastrointestinal function. Disruption of these interactions by ...